Therapeutic Efficacy of Tiludronic Acid on Inner Ear Involvement in Advanced Otosclerosis
Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy of a biphosphonate (tiludronic acid, Skelid®,
Sanofi-Aventis) in the treatment of inner ear involvement in advanced otosclerosis